LexaGene Holdings Inc.

TSXV:LXG.H Stock Report

Market Cap: CA$14.8m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

LexaGene Holdings Past Earnings Performance

Past criteria checks 0/6

LexaGene Holdings's earnings have been declining at an average annual rate of -14.5%, while the Medical Equipment industry saw earnings growing at 9.9% annually. Revenues have been growing at an average rate of 74.5% per year.

Key information

-14.5%

Earnings growth rate

4.3%

EPS growth rate

Medical Equipment Industry Growth-19.2%
Revenue growth rate74.5%
Return on equity-670.7%
Net Margin-8,189.9%
Last Earnings Update30 Nov 2022

Recent past performance updates

No updates

Recent updates

It's Unlikely That LexaGene Holdings Inc.'s (CVE:LXG) CEO Will See A Huge Pay Rise This Year

Feb 02
It's Unlikely That LexaGene Holdings Inc.'s (CVE:LXG) CEO Will See A Huge Pay Rise This Year

We're A Little Worried About LexaGene Holdings' (CVE:LXG) Cash Burn Rate

Oct 07
We're A Little Worried About LexaGene Holdings' (CVE:LXG) Cash Burn Rate

Here's Why We're Not Too Worried About LexaGene Holdings' (CVE:LXG) Cash Burn Situation

May 17
Here's Why We're Not Too Worried About LexaGene Holdings' (CVE:LXG) Cash Burn Situation

We Think LexaGene Holdings (CVE:LXG) Can Afford To Drive Business Growth

Feb 01
We Think LexaGene Holdings (CVE:LXG) Can Afford To Drive Business Growth

Revenue & Expenses Breakdown
Beta

How LexaGene Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TSXV:LXG.H Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Nov 220-935
31 Aug 220-1045
31 May 220-1046
28 Feb 220-1146
30 Nov 210-1156
31 Aug 210-1156
31 May 210-1156
28 Feb 210-1046
30 Nov 200-945
31 Aug 200-935
31 May 200-835
29 Feb 200-734
30 Nov 190-835
31 Aug 190-835
31 May 190-835
28 Feb 190-835
30 Nov 180-735
31 Aug 180-724
31 May 180-523
28 Feb 180-412
30 Nov 170-322
31 Aug 170-611
31 May 170-511
28 Feb 170-410
30 Nov 160-400
31 Aug 160000

Quality Earnings: LXG.H is currently unprofitable.

Growing Profit Margin: LXG.H is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: LXG.H is unprofitable, and losses have increased over the past 5 years at a rate of 14.5% per year.

Accelerating Growth: Unable to compare LXG.H's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: LXG.H is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (1.2%).


Return on Equity

High ROE: LXG.H has a negative Return on Equity (-670.69%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.